
How Recent 340B Changes Impact Specialty Pharmacies In 2025
The evolving legal and legislative landscape surrounding the 340B Drug Pricing Program has significant implications for hospitals’ specialty pharmacies. Here’s a breakdown of the new

The evolving legal and legislative landscape surrounding the 340B Drug Pricing Program has significant implications for hospitals’ specialty pharmacies. Here’s a breakdown of the new

When it comes to optimizing patient outcomes, hospital readmission rates, and pharmacy revenue, ProxsysRx’s Meds To Beds program delivers more than just bedside service—it delivers

Maximizing pharmacy’s role in your hospital’s revenue cycle The 340B landscape continues to evolve rapidly, with ongoing manufacturer restrictions, new compliance hurdles, and increasing financial
DISTRIBUTION: 340B SOLUTIONS, MANAGEMENT SYSTEMS The 340B Drug Pricing Program is vital for safety-net healthcare providers, allowing them to enhance access to medications, reduce medication
How health systems can leverage visibility, their PBM and their pharmacies to achieve their financial and clinical goals. The systemic problem: OverviewThe U.S. prescription drug
Birmingham’s ProxsysRx has agreed to a strategic combination with Maxor National Pharmacy Services (“Maxor”), positioning the combined entity as the largest independent provider of pharmacy
Fair Warning: If you ever dismissively ask that question (above) of someone who’s led the planning and launch of a 340B hospital’s specialty pharmacy, and
The Pharmacy500 is awarded to 500 supply chain businesses and associations that have made a significant impact on dispensing pharmacies in the U.S. over the
The Pharmacy500 is awarded to 500 supply chain businesses and associations that have made a significant impact on dispensing pharmacies in the U.S. over the